PT782569E - Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos - Google Patents

Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos

Info

Publication number
PT782569E
PT782569E PT95932092T PT95932092T PT782569E PT 782569 E PT782569 E PT 782569E PT 95932092 T PT95932092 T PT 95932092T PT 95932092 T PT95932092 T PT 95932092T PT 782569 E PT782569 E PT 782569E
Authority
PT
Portugal
Prior art keywords
pct
compound
date
levobupivacaine
racemization
Prior art date
Application number
PT95932092T
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Christopher James Lock
Martin Woods
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504927.6A external-priority patent/GB9504927D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of PT782569E publication Critical patent/PT782569E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
PT95932092T 1994-09-23 1995-09-22 Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos PT782569E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94306962 1994-09-23
GBGB9504927.6A GB9504927D0 (en) 1995-03-10 1995-03-10 Racemisation and asymmetric transformation

Publications (1)

Publication Number Publication Date
PT782569E true PT782569E (pt) 2002-09-30

Family

ID=26137306

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95932092T PT782569E (pt) 1994-09-23 1995-09-22 Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos

Country Status (18)

Country Link
US (1) US5786484A (pt)
EP (1) EP0782569B1 (pt)
JP (1) JP3898220B2 (pt)
KR (1) KR100393133B1 (pt)
CN (1) CN1104416C (pt)
AT (1) ATE214695T1 (pt)
AU (1) AU695479B2 (pt)
CA (1) CA2200490C (pt)
DE (1) DE69525950T2 (pt)
DK (1) DK0782569T3 (pt)
ES (1) ES2173194T3 (pt)
FI (1) FI117436B (pt)
HU (1) HU216291B (pt)
MX (1) MX9702210A (pt)
NO (1) NO308074B1 (pt)
PL (1) PL183204B1 (pt)
PT (1) PT782569E (pt)
WO (1) WO1996009290A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384227B2 (en) 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2000256359A (ja) * 1999-03-11 2000-09-19 Japan Science & Technology Corp 面性キラリティーを有する分子群の高選択的不斉変換法
US6288280B1 (en) * 1999-07-09 2001-09-11 Hoffmann-La Roche Inc. Racemization of atropisomeric bis(phosphine oxide) compounds
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2001096301A1 (fr) * 2000-06-14 2001-12-20 Toray Industries, Inc. Procedes de production de derive de piperidine racemique et de production de derive de piperidine a activite optique
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
US20100260844A1 (en) * 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
JP2021526513A (ja) * 2018-05-18 2021-10-07 クラ オンコロジー， インコーポレイテッド ティピファニブの合成
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
US5786484A (en) 1998-07-28
FI971202A (fi) 1997-03-21
HU216291B (hu) 1999-06-28
CN1159184A (zh) 1997-09-10
MX9702210A (es) 1998-05-31
CN1104416C (zh) 2003-04-02
JPH10505855A (ja) 1998-06-09
NO971358L (no) 1997-03-21
DE69525950D1 (de) 2002-04-25
DE69525950T2 (de) 2002-09-19
AU3527995A (en) 1996-04-09
NO308074B1 (no) 2000-07-17
JP3898220B2 (ja) 2007-03-28
EP0782569B1 (en) 2002-03-20
CA2200490A1 (en) 1996-03-28
FI971202A0 (fi) 1997-03-21
KR100393133B1 (ko) 2003-11-17
ATE214695T1 (de) 2002-04-15
NO971358D0 (no) 1997-03-21
AU695479B2 (en) 1998-08-13
EP0782569A1 (en) 1997-07-09
HUT77055A (hu) 1998-03-02
PL319368A1 (en) 1997-08-04
CA2200490C (en) 2007-01-09
DK0782569T3 (da) 2002-07-22
WO1996009290A1 (en) 1996-03-28
FI117436B (fi) 2006-10-13
ES2173194T3 (es) 2002-10-16
PL183204B1 (pl) 2002-06-28

Similar Documents

Publication Publication Date Title
PT782569E (pt) Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos
DE59607490D1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
NO964346L (no) Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
SE9501808D0 (sv) New process
ATE182879T1 (de) Neuartig substituierte dtpa-derivate, deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie, sowie verfahren zur herstellung der komplexe und mittel
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
DE69606411T2 (de) Verfahren zur herstellung von liponsaeure
PT793666E (pt) Processo de sililacao
NO990159D0 (no) FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer
DE59605316D1 (de) Verfahren zur herstellung von beta-amino-alpha-hydroxycarbonsäuren und deren derivaten
DE59808082D1 (de) Verfahren zur herstellung von langkettigen glycin-n,n-diessigsäure-derivaten
PT784603E (pt) Racemizacao de precursores de levobupivacaina e seus analogos
ATE421953T1 (de) Verfahren zur racemisierung von 1-benzyl-4-(4- fluorophenyl)-3-hydroxymethyl-1,2,3,6- tetrahydropyridin und dessen verwendung in der synthese von paroxetin